US Diagnostic plans merger

Article

US Diagnostic has a tentative agreement to merge with International Radiology Group. According to terms of a letter of agreement between the two companies, USD would acquire all of the fully diluted membership units of IRG for 49% of the issued shares of

US Diagnostic has a tentative agreement to merge with International Radiology Group. According to terms of a letter of agreement between the two companies, USD would acquire all of the fully diluted membership units of IRG for 49% of the issued shares of the combined entity, $5 million in cash, $5 million in a five-year subordinated unsecured debenture, and performance-based warrants. The transaction is subject to due diligence and other conditions, including regulatory approval and shareholder consent. If the merger goes through, which could happen in the second quarter of 2001, representatives of IRG will have a majority of the board seats of the combined entity.

US Diagnostic, an independent provider of radiology services, owns, operates, or manages 47 fixed sites in 12 states. IRG and its subsidiary American Imaging Management manage radiology benefits for managed-care organizations covering approximately three million lives.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.